| Alternative splicing results in RET isoforms with distinct trafficking properties DS Richardson, DM Rodrigues, BD Hyndman, MJF Crupi, AC Nicolescu, ... Molecular Biology of the Cell 23 (19), 3838-3850, 2012 | 63 | 2012 |
| Differential roles of RET isoforms in medullary and papillary thyroid carcinomas EY Lian, SM Maritan, JG Cockburn, K Kasaian, MJ Crupi, D Hurlbut, ... Endocr Relat Cancer 24 (1), 53-69, 2017 | 40 | 2017 |
| Characterization of critical determinants of ACE2–SARS CoV-2 RBD interaction EEF Brown, R Rezaei, TR Jamieson, J Dave, NT Martin, R Singaravelu, ... International Journal of Molecular Sciences 22 (5), 2268, 2021 | 36 | 2021 |
| Distinct temporal regulation of RET isoform internalization: roles of clathrin and AP2 MJF Crupi, P Yoganathan, LN Bone, E Lian, A Fetz, CN Antonescu, ... Traffic 16 (11), 1155-1173, 2015 | 31 | 2015 |
| Concise review: targeting cancer stem cells and their supporting niche using oncolytic viruses MJF Crupi, JC Bell, R Singaravelu Stem Cells 37 (6), 716-723, 2019 | 27 | 2019 |
| Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization BD Hyndman, MJF Crupi, S Peng, LN Bone, AN Rekab, EY Lian, ... Journal of Cell Science 130 (19), 3282-3296, 2017 | 27 | 2017 |
| Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry T Azad, R Singaravelu, Z Taha, TR Jamieson, S Boulton, MJF Crupi, ... Molecular Therapy 29 (6), 1984-2000, 2021 | 26 | 2021 |
| Implications for SARS-CoV-2 vaccine design: Fusion of spike glycoprotein transmembrane domain to receptor-binding domain induces trimerization T Azad, R Singaravelu, MJF Crupi, T Jamieson, J Dave, EEF Brown, ... Membranes 10 (9), 215, 2020 | 25 | 2020 |
| Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy ME Wedge, VA Jennings, MJF Crupi, J Poutou, T Jamieson, A Pelin, ... Nature communications 13 (1), 1898, 2022 | 23 | 2022 |
| GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion MJF Crupi, SM Maritan, E Reyes-Alvarez, EY Lian, BD Hyndman, ... Oncogene 39 (6), 1361-1377, 2020 | 23 | 2020 |
| Extracellular vesicles and viruses: two intertwined entities C Moulin, MJF Crupi, CS Ilkow, JC Bell, S Boulton International Journal of Molecular Sciences 24 (2), 1036, 2023 | 19 | 2023 |
| Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection S Boulton, J Poutou, NT Martin, T Azad, R Singaravelu, MJF Crupi, ... Molecular Therapy 30 (5), 1885-1896, 2022 | 18 | 2022 |
| Cell surface biotinylation of receptor tyrosine kinases to investigate intracellular trafficking MJF Crupi, DS Richardson, LM Mulligan Receptor Tyrosine Kinases: Methods and Protocols, 91-102, 2015 | 15 | 2015 |
| Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer MJF Crupi, Z Taha, TJA Janssen, J Petryk, S Boulton, N Alluqmani, ... Frontiers in Immunology 13, 1029269, 2022 | 14 | 2022 |
| RET isoform-specific interaction with scaffold protein Ezrin promotes cell migration and chemotaxis in lung adenocarcinoma S Moodley, EY Lian, MJF Crupi, BD Hyndman, LM Mulligan Lung Cancer 142, 123-131, 2020 | 13 | 2020 |
| A high-throughput NanoBiT-based serological assay detects SARS-CoV-2 seroconversion T Azad, R Rezaei, R Singaravelu, TR Jamieson, MJF Crupi, A Surendran, ... Nanomaterials 11 (3), 807, 2021 | 12 | 2021 |
| Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference D Bastin, AS Aitken, A Pelin, LA Pikor, MJF Crupi, MS Huh, ... Journal for ImmunoTherapy of Cancer 6, 1-12, 2018 | 12 | 2018 |
| Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies T Azad, R Rezaei, R Singaravelu, A Pelin, S Boulton, J Petryk, KA Onsu, ... Nature communications 14 (1), 3035, 2023 | 11 | 2023 |
| Luciferase-based biosensors in the era of the COVID-19 pandemic T Azad, HJ Janse van Rensburg, J Morgan, R Rezaei, MJF Crupi, R Chen, ... ACS Nanoscience Au 1 (1), 15-37, 2021 | 10 | 2021 |
| Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen Z Taha, R Arulanandam, G Maznyi, E Godbout, ME Carter-Timofte, ... Molecular Therapy 30 (9), 2998-3016, 2022 | 7 | 2022 |
